Semaglutide Tablets
Formulated to manage type 2 diabetes mellitus and to support weight loss by mimicking natural hormones to regulate blood sugar and appetite levels.
Strengths: 3 · 7 · 14mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Rybelsus; Ozempic
- Therapeutic class
GLP-1 Receptor Agonist
- Pharmacological class
GLP-1 Receptor Agonist
- Known off-label uses
obesity
- Minor side effects
nausea; diarrhoea; abdominal pain; vomiting
- Moderate side effects
dyspepsia; flatulence; gastro-oesophageal reflux disease; fatigue
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Novo Nordisk
- Onset Time
4–8 weeks
- Duration
constant
- Storage instructions
Store below 25°C, away from sunlight and moisture.
- Drug interactions
insulin; sulfonylureas
- Age restrictions
Adults 18 years and older.
- Pregnancy and breastfeeding
Pregnancy: Not recommended. Breastfeeding: Not recommended.
Contraindications
hypersensitivity to semaglutide; personal or family history of medullary thyroid carcinoma; multiple endocrine neoplasia syndrome type 2
Precautions and warnings
monitor for signs of pancreatitis; maintain adequate hydration to reduce kidney-related risk; report any symptoms of gallstones or gallbladder inflammation
Serious side effects
pancreatitis — requires immediate medical attention; anaphylaxis — requires immediate medical attention; diabetic retinopathy complications — requires immediate medical attention
Patient summary
Formulated to manage type 2 diabetes mellitus and to support weight loss by mimicking natural hormones to regulate blood sugar and appetite levels.
Mechanism of action
Semaglutide is a glucagon-like peptide-1 receptor agonist. It stimulates insulin secretion and lowers glucagon secretion in a glucose-dependent manner, while also delaying gastric emptying and increasing satiety, which helps manage blood sugar levels and body weight.
Semaglutide Tablets
Formulated to manage type 2 diabetes mellitus and to support weight loss by mimicking natural hormones to regulate blood sugar and appetite levels.
Editorial Notes
- Active ingredient(s): Semaglutide
- Listed indication(s): Type 2 Diabetes Mellitus
Usually available as
- 10 tablets - 3 mg1133-3-mg-13426
- 10 tablets - 7 mg1133-7-mg-13431
- 10 tablets - 14 mg1133-14-mg-13436